CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxA longevity-leaning telehealth brand with some of the lower compounded-semaglutide pricing.
Visit AgelessRxCoreAge Rx takes it with a higher Verdict Score — 94/100 to 86/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. AgelessRx still earns its place — budget-conscious patients who also value a longevity-medicine framing.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | CoreAge Rx | AgelessRx |
|---|---|---|
| Verdict Score | 94/100 | 86/100 |
| Grade | A | B |
| Semaglutide | $149/mo | $139/mo |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
What we like
The caveats
What we like
The caveats
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Budget-conscious patients who also value a longevity-medicine framing.
Visit AgelessRx Read the full AgelessRx review →Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for AgelessRx does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.